Navigation Links
Wyss Institute at Harvard University announces election of 2 faculty to Natl Academy of Inventors

Wyss Core Faculty members George Whitesides, Ph.D., and David Edwards, Ph.D., have been named Fellows of the National Academy of Inventors (NAI) joining 141 other innovators elected this year.

NAI Fellow status is a high professional distinction accorded to academic inventors who have demonstrated a prolific spirit of innovation in creating inventions that have made a tangible impact on quality of life, economic development, and the welfare of society. Together, this year's NAI Fellows hold more than 5,600 U.S. patents.

"The impressive spectrum of technologies generated by the Whitesides and Edwards teams reflects the ambition and vigor of the Wyss Institute model," said Wyss Institute Founding Director Don Ingber, Ph.D. "It is wonderful to see their innovations recognized by such a prestigious academy."

In addition to his affiliation with the Wyss Institute, George Whitesides the most cited chemist in the world and author of more than 950 scientific articles and numerous patents is also the Woodford L. and Ann A. Flowers University Professor at Harvard University. His work spans many disciplines, including physical and organic chemistry, materials science, biophysics, microfluidics, self-assembly, micro- and nanotechnology, science for developing economies, origin of life, cell-surface biochemistry, and more.

Whitesides is working with other Wyss researchers to pioneer advancements in soft robotics taking cues from flexible organisms such as the octopus to inspire the next generation of medical devices. He is also developing diagnostic tools that are low cost, simple to use, and durable enough to withstand conditions in rural areas and in the developing world. For example, he has incorporated advanced microfluidics into paper-based devices about the size of a postage stamp that can be used by laypeople to diagnose diseases such as diabetes.

Whitesides has received dozens of awards, including the Dreyfus Prize in the Chemical Sciences for his creation of new materials that have significantly advanced the field of chemistry and its societal benefits. He has also received the Priestley Medalthe highest honor bestowed by the American Chemical Societyand the Benjamin Franklin Medal in Chemistry for his pioneering research in molecular self-assembly and innovative nanofabrication techniques. He also received the President's National Medal of Science, and is a member of the National Academy of Sciences and a Fellow of numerous societies.

In addition to his Wyss Core Faculty position, David Edwards - one of the youngest members ever elected to the US and French National Academies of Engineering - is also the Gordon McKay Professor of the Practice of Idea Translation at Harvard's School of Engineering and Applied Sciences (SEAS). Edwards combines the logic of science with the creativity of art to develop technological advances, design solutions, and creative partnerships around the world. He founded and directs Le Laboratoire in Paris that is also soon to open a new branch in Cambridge, MA, which brings artists and scientists together to develop new innovations, often engaging Edwards and his students in the context of his Wyss Institute research. Among Edwards' new innovations in recent years are: a packaging platform for food and beverage products that avoids plastic and other damaging materials, inspired by fruits and vegetables; a platform for delivering nutrition via the air for better healthcare, including chocolate without calories, and vitamins and supplements without pills; and the oPhone, a new platform for delivering complex olfactory signals for healthcare, entertainment, and global communications.

The Wyss Institute also supports Edwards' Idea Translation program at Harvard an innovation "bootcamp" for college students that offers a new model of experimental learning, and commercializes their ideas into products with social benefit. Among Harvard Global Health Institute and Wyss-backed innovations emanating from Edwards' Idea Translation program is the CellBag, a gourd for carrying water in the special conditions of the developing world, and now used and distributed in South Africa in rural villages, and Soccket, a soccer ball that generates electricity to power cell phones in the developing world. Edwards has won multiple international awards, including being a three-time recipient of the Ebert Prize of the American Pharmaceutical Association for his early work in drug and vaccine delivery.

Says David Edwards, "I am deeply honored to receive this distinction with incredibly inventive colleagues from here at Harvard University and across the country, and appreciative of the unique support of the Wyss Institute and the School of Engineering and Applied Sciences at Harvard."

Wyss Core Faculty member Jim Collins, Ph.D., is also an NAI fellow. He is also the William F. Warren Distinguished Professor at Boston University, where he leads the Center of Synthetic Biology.


Contact: Kristen Kusek
Wyss Institute for Biologically Inspired Engineering at Harvard

Related biology news :

1. Diabetes Research Institute develops oxygen-generating biomaterial
2. Space research institute honors Sen. Hutchison with Pioneer Award
3. Scripps Research Institute scientists find promising vaccine targets on hepatitis C virus
4. Minneapolis Heart Institute selected to participate in Cardiovascular Cell Therapy Research Network
5. Cary Institute Hydrofracking Forum
6. Scripps Research Institute Professor Gerald F. Joyce elected to American Academy of Arts & Sciences
7. Scripps Research Institute scientists develop antidote for cocaine overdose
8. NJIT, Chinas Bengbu Glass Institute sign agreement for R&D, training
9. Merkin Family Foundation to fund next generation of Broad Institute scientists
10. TGen leads new National Institutes of Health study of brain tumors
11. CUNY Energy Institute battery system could reduce buildings electric bills
Post Your Comments:
Related Image:
Wyss Institute at Harvard University announces election of 2 faculty to Natl Academy of Inventors
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... , Oct. 29, 2015  The J. Craig Venter ... titled, "DNA Synthesis and Biosecurity: Lessons Learned and Options ... of Health and Human Services guidance for synthetic biology ... --> --> ... has the potential to pose unique biosecurity threats. It ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... ... November 24, 2015 , ... This fall, global software solutions leader SAP and ... to develop and pitch their BIG ideas to improve health and wellness in their ... votes to win the title of SAP's Teen Innovator, an all-expenses paid trip to ...
(Date:11/24/2015)... New York , November 24, 2015 ... to a recent market research report released by Transparency ... projected to expand at a CAGR of 17.5% during ... "Non-invasive Prenatal Testing Market - Global Industry Analysis, Size, ... estimates the global non-invasive prenatal testing market to reach ...
(Date:11/24/2015)...  Twist Bioscience, a company focused on synthetic ... Bioscience chief executive officer, will present at the ... 2015 at 3:10 p.m. Eastern Time at The Lotte New ... --> --> About Twist ... on Twitter. Sign up to follow our Twitter ...
(Date:11/24/2015)... Vancouver, BC (PRWEB) , ... November 24, 2015 ... ... to our customer, OrthoAccel® Technologies, Inc., on being named to Deloitte's 2015 Technology ... Creation Technologies’ Texas facility, OrthoAccel manufactures AcceleDent®, a FDA-cleared, Class II medical device ...
Breaking Biology Technology: